Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-22
2006-08-22
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S310000, C546S139000, C546S143000
Reexamination Certificate
active
07094789
ABSTRACT:
A compound represented by the following formula (1) or a salt thereof:wherein R1represents hydrogen atom, a halogen atom and the like; R2represents hydrogen atom, a halogen atom, a C1-6alkyl group and the like; and R3represents —O—X—C(A1)(A11)-C(A2)(A21)-N(A31)(A3) (X represents propylene group etc., A11and A21represent hydrogen atom, or a C1-6alkyl group, A31represents a C1-6alkyl group substituted with hydroxyl group, or hydrogen atom, and A1, A2, and A3represent hydrogen atom, a C1-6alkyl group and the like) and the like, which has an inhibitory activity on the phosphorylation of myosin regulatory light chain, and is useful for treatment of diseases relating to contraction of various cells and the like.
REFERENCES:
patent: 3101338 (1963-08-01), Robinson
patent: 4473501 (1984-09-01), Lowrie
patent: 4520025 (1985-05-01), Campbell et al.
patent: 4798897 (1989-01-01), Hidaka et al.
patent: 5362878 (1994-11-01), Chang et al.
patent: 5656634 (1997-08-01), Chang et al.
patent: 6153608 (2000-11-01), Hidaka et al.
patent: 6262112 (2001-07-01), Mittendorf et al.
patent: 6281243 (2001-08-01), Leysen et al.
patent: 6403573 (2002-06-01), Leysen et al.
patent: 2003/0004158 (2003-01-01), Scarborough et al.
patent: 2 350 208 (2000-05-01), None
patent: 0 061 673 (1984-10-01), None
patent: 0863136 (1998-09-01), None
patent: 0 956 865 (1999-11-01), None
patent: 0956865 (1999-11-01), None
patent: 1 065 200 (2001-01-01), None
patent: 1 256 574 (2002-11-01), None
patent: 0 966 436 (2002-12-01), None
patent: 2065121 (1981-06-01), None
patent: 62-103066 (1987-05-01), None
patent: 10-87629 (1998-04-01), None
patent: 2002-145778 (2002-05-01), None
patent: 3408546 (2003-03-01), None
patent: WO 93/15073 (1993-08-01), None
patent: WO 99/20620 (1999-04-01), None
patent: WO 99/43647 (1999-09-01), None
patent: WO 00/27819 (2000-03-01), None
patent: WO-01/56988 (2001-08-01), None
Suzuki et al., Br. J. Pharmacol. (1993), 109, 703-712.
P. H. Howe et al., Biochem J. (1988) 255, 423-429.
P. L. Mobley, Experimental Cell Research, 214, 55-66 (1994).
Seto Minoru
Yamada Rintaro
Asahi Kasei Pharma Corporation
Birch & Stewart Kolasch & Birch, LLP
Davis Zinna N.
LandOfFree
5-substituted isoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-substituted isoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-substituted isoquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3616439